ABT
Abbott Laboratories · Healthcare · Medical Devices
TECHSellZACKSBuy
R500#166 today
$97.50
+0.84% today · -3.74% 1W
Oct 2 close or latest
PreviewWhy it's moving
Moving with the market
- ABT +0.84% on the last session vs SPY +0.74%: +0.1 pts of stock-specific move.
- Aftermath, rsi oversold (Sep 30): After its 17 oversold readings in the past 5 years, ABT typically gained 0.6% over the next day (median) and was higher 53% of the time; half the outcomes fell between -1.1% and +1.3%. An ordinary day: +0.0%. Among S&P 500 stocks after oversold readings, that ranks #52 of 496.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
Next report
Oct 21
Before the open · in 17 days
EPS estimate
$1.42
$1.41 to $1.44 · 22 analysts
Revenue estimate
$13.0B
$12.9B to $13.2B
Track record
4/8 beats
last 8 reports · moved ±5.4% on average
Reports
| Reported | Quarter | EPS est. | EPS | EPS surprise | Revenue | Reaction | Gap | 5 days |
|---|---|---|---|---|---|---|---|---|
| Jul 16, 2026 BMO | 2Q2026 | $1.28 | $1.31 | +$0.03 (+2.6%) beat | — | +10.7% +11.2 vs SPY | +6.7% | +12.7% |
| Apr 16, 2026 BMO | 1Q2026 | $1.15 | $1.15 | +$0.00 (+0.3%) in line | — | -6.0% -6.2 vs SPY | -4.4% | -9.7% |
| Jan 22, 2026 BMO | 4Q2025 | $1.49 | $1.50 | +$0.01 (+0.3%) beat | — | -10.0% -10.6 vs SPY | -10.9% | -12.2% |
| Oct 15, 2025 BMO | 3Q2025 | $1.30 | $1.30 | +$0.00 (+0.0%) in line | — | -2.4% -2.9 vs SPY | -3.5% | -3.9% |
| Jul 17, 2025 BMO | $1.26 | $1.26 | $0.00 (0.0%) in line | — | -8.5% -9.1 vs SPY | -3.9% | -4.5% | |
| Apr 16, 2025 BMO | $1.07 | $1.09 | +$0.02 (+1.9%) beat | — | +2.8% +5.0 vs SPY | +2.8% | +2.9% | |
| Jan 22, 2025 BMO | $1.34 | $1.34 | $0.00 (0.0%) in line | — | +0.8% +0.3 vs SPY | -2.3% | +9.1% | |
| Oct 16, 2024 BMO | $1.20 | $1.21 | +$0.01 (+0.8%) beat | — | +1.5% +1.1 vs SPY | +1.7% | +0.1% | |
| Jul 18, 2024 BMO | $1.10 | $1.14 | +$0.04 (+3.6%) beat | — | -4.4% -3.6 vs SPY | -2.2% | +2.5% | |
| Apr 17, 2024 BMO | $0.95 | $0.98 | +$0.03 (+3.2%) beat | — | -3.0% -2.4 vs SPY | -1.5% | -1.5% | |
| Jan 24, 2024 BMO | $1.19 | $1.19 | $0.00 (0.0%) in line | — | -2.8% -2.9 vs SPY | -2.9% | -0.5% | |
| Oct 18, 2023 BMO | $1.10 | $1.14 | +$0.04 (+3.6%) beat | — | +3.7% +5.0 vs SPY | +4.2% | +2.9% | |
| Jul 20, 2023 BMO | $1.05 | $1.08 | +$0.03 (+2.9%) beat | — | +4.2% +4.9 vs SPY | +0.8% | +6.3% | |
| Apr 19, 2023 BMO | $0.99 | $1.03 | +$0.04 (+4.0%) beat | — | +7.8% +7.8 vs SPY | +4.2% | +5.6% | |
| Jan 25, 2023 BMO | $0.94 | $1.03 | +$0.09 (+9.6%) beat | — | -1.4% -1.4 vs SPY | -2.2% | -1.8% | |
| Oct 19, 2022 BMO | $0.94 | $1.15 | +$0.21 (+22.3%) beat | — | -6.5% -5.8 vs SPY | -3.8% | -6.7% | |
| Jul 20, 2022 BMO | $1.14 | $1.43 | +$0.29 (+25.4%) beat | — | -1.6% -2.2 vs SPY | -2.7% | -0.8% | |
| Apr 20, 2022 BMO | $1.46 | $1.73 | +$0.27 (+18.5%) beat | — | +2.2% +2.3 vs SPY | -0.4% | -2.5% | |
| Jan 26, 2022 BMO | $1.21 | $1.32 | +$0.11 (+9.1%) beat | — | -2.6% -2.4 vs SPY | -3.3% | +3.2% | |
| Oct 20, 2021 BMO | $0.95 | $1.40 | +$0.45 (+47.4%) beat | — | +3.3% +2.9 vs SPY | +3.5% | +7.4% | |
| Jul 22, 2021 BMO | $1.02 | $1.17 | +$0.15 (+14.7%) beat | — | — | — | — | |
| Apr 20, 2021 BMO | $1.27 | $1.32 | +$0.05 (+3.9%) beat | — | — | — | — | |
| Jan 27, 2021 BMO | $1.35 | $1.45 | +$0.10 (+7.4%) beat | — | — | — | — | |
| Oct 21, 2020 BMO | $0.91 | $0.98 | +$0.07 (+7.7%) beat | — | — | — | — |
BMO = before the open, AMC = after the close. Reaction: the first session that could trade on the report (the same day for BMO, the next session for AMC) against the close before it; "vs SPY" subtracts the S&P 500 over the same session. EPS surprise is in dollars, with the percentage only when the estimate is at least $0.10 (near zero, a small beat would show as hundreds of percent). Revenue surprise needs the estimate from before the report, so it starts with the reports Wallsti saw coming.
Analyst estimates
| Period | EPS | Range | vs year ago | 90-day trend | Revisions 30d | Revenue | vs year ago |
|---|---|---|---|---|---|---|---|
| Current quarter · Sep 30, 2026 | $1.42 (22) | $1.41 – $1.44 | +9% | -0.1% | ▲7 ▼10 | $13.0B | +14% |
| Next quarter · Dec 31, 2026 | $1.64 (22) | $1.59 – $1.67 | +9% | +1.3% | ▲15 ▼0 | $13.5B | +18% |
| Current year · Dec 31, 2026 | $5.52 (26) | $5.48 – $5.57 | +7% | +0.7% | ▲5 ▼1 | $50.2B | +13% |
| Next year · Dec 31, 2027 | $6.07 (26) | $5.88 – $6.20 | +10% | +0.1% | ▲3 ▼2 | $54.5B | +9% |
Consensus as of Oct 4, 2026. Source: Yahoo Finance analyst estimates; schedule and timing also from Nasdaq's earnings calendar.